Chemotherapy plus ponatinib: a new standard for Ph-positive ALL?

被引：3

作者：

Thomas, Xavier ^{[1
]}

机构：

[1] Lyon Sud Hosp, Hosp Civils Lyon, Hematol, F-69495 Pierre Benite, France

来源：

LANCET ONCOLOGY | 2015年 / 16卷 / 15期

关键词：

ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; IMATINIB; RESISTANCE; INHIBITOR; PHASE-2;

D O I：

10.1016/S1470-2045(15)00247-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1451 / 1453

页数：4

共 50 条

[31] PH-POSITIVE LEUKEMIA - A TRANSGENIC MOUSE MODEL
GROFFEN, J
VONCKEN, JW
KAARTINEN, V
MORRIS, C
HEISTERKAMP, N
LEUKEMIA & LYMPHOMA, 1993, 11 : 19 - 24
[32] Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia
Nishida, Hiroko
Yoshimizu, Natsuko
Ueno, Hironori
Fujita, Ayumi
Kato, Takayasu
Park, Jae Wong
Yano, Takahiro
Tobinai, Kensei
Ikeda, Yasuo
LEUKEMIA RESEARCH, 2007, 31 (03) : 417 - 418
[33] The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults
M R Litzow
A K Fielding
S M Luger
E Paietta
Y Ofran
J M Rowe
A H Goldstone
M S Tallman
H M Lazarus
Bone Marrow Transplantation, 2017, 52 : 1592 - 1598
[34] A phase II trial of ponatinib and blinatumomab in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
Short, Nicholas James
Jabbour, Elias
Jain, Nitin
Macaron, Walid
Huang, Xuelin
Montalban-Bravo, Guillermo
Kadia, Tapan M.
Daver, Naval Guastad
Haddad, Fadi
Zoghbi, Marianne
Nasnas, Cedric Christophe
Nasr, Lewis Fady
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Loiselle, Christopher
Garris, Rebecca
Konopleva, Marina
Ravandi, Farhad
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[35] Secondary chromosomal aberrations in 255 childhood cases of Ph-positive acute lymphoblastic leukemia (ALL).
Harbott, J
Heerema, NA
Baruchel, A
Camitta, BM
Chessells, JM
Gaynon, PS
Janka-Schaub, G
Pui, CH
Sallan, SE
Schrappe, M
Valsecchi, MG
Aricò, M
BLOOD, 2000, 96 (11) : 710A - 710A
[36] The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults
Litzow, M. R.
Fielding, A. K.
Luger, S. M.
Paietta, E.
Ofran, Y.
Rowe, J. M.
Goldstone, A. H.
Tallman, M. S.
Lazarus, H. M.
BONE MARROW TRANSPLANTATION, 2017, 52 (12) : 1592 - 1598
[37] DEBATE: IN PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA, DE WE NEED CHEMOTHERAPY IN INDUCTION THERAPY?
Ribera, Josep-Maria
LEUKEMIA RESEARCH, 2015, 39 : SS3 - SS3
[38] NEAR-TRIPLOID PH-POSITIVE LEUKEMIA
OHTAKI, K
ABE, R
TEBBI, CK
DELOSSANTOS, R
HAN, T
SANDBERG, AA
CANCER GENETICS AND CYTOGENETICS, 1985, 18 (02) : 113 - 121
[39] Efficacy and Toxicity of Frontline Ponatinib Plus Blinatumomab for Adult Ph plus ALL Patients of All Ages. Intermediate Analysis of the Gimema ALL2820
Chiaretti, Sabina
Leoncin, Matteo
Elia, Loredana
Soddu, Stefano
Piciocchi, Alfonso
Matarazzo, Mabel
Di Trani, Mariangela
Martelli, Maurizio
Borlenghi, Erika
Parisi, Marina
Mancini, Valentina
Alati, Caterina
Mattei, Daniele G.
Martelli, Maria Paola
Salutari, Prassede
Chiusolo, Patrizia
Audisio, Ernesta
Luppi, Mario
Pochintesta, Lara
Pasciolla, Crescenza
Serio, Bianca
Scappini, Barbara
Cucca, Antonella
Chiarucci, Martina
Bonifacio, Massimiliano
Fracchiolla, Nicola
Imbergamo, Silvia
Ammirati, Lucia
Mosna, Federico
Zappasodi, Patrizia
Mastaglio, Sara
Pietrasanta, Daniela
Bocchia, Monica
Lunghi, Monia
Todisco, Elisabetta
Fazi, Paola
Rambaldi, Alessandro
Foa, Robin
BLOOD, 2024, 144 : 835 - 837
[40] EVALUATION OF MRD MONITORING IN PERIPHERAL BLOOD VS BONE MARROW SOURCE IN PH-POSITIVE ALL
Attardi, E.
Savi, A.
Sini, D.
Conti, C.
Nardozza, A. M.
Meddi, E.
Mallegni, F.
Ranucci, G.
Buzzatti, E.
Ottone, T.
Gurnari, C.
Divona, M.
Cefalo, M. G.
Locatelli, F.
Del Principe, M. I.
Voso, M. T.
HAEMATOLOGICA, 2024, 109 : 85 - 86

← 1 2 3 4 5 →